Poland· PL-100204573
Antytoksyna botulinowa A B E
A botulismus-antitoxin product containing immunoserum botulinicum, registered in Poland by Wytwórnia Surowic i Szczepionek Biomed Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Botulismus-antitoxin is registered in 4 of 19 countries.
Countries holding a registration under ATC J06AA04 (botulismus-antitoxin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Botulismus-antitoxin · ATC J06AA04
4 / 19 countries
- Czechiaprice
- Ireland
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Immunoserum botulinicum
- Manufacturer
- Wytwórnia Surowic i Szczepionek Biomed Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- J06AA04
- ATC class
- Botulismus-Antitoxin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990053018
- gtin05909990763221
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J06AA04
Botulismus-antitoxin, as other registers publish it.
- CzechiaANTYTOKSYNA BOTULINOWA ABE
- CzechiaANTYTOKSYNA BOTULINOWA ABE
- NorwayAntytoksyna botulinowa ABE biomed
- CzechiaBAT [BOTULISM ANTITOXIN HEPTAVALENT (A, B, C, D, E, F, G) (EQUINE)
- CzechiaBAT [BOTULISM ANTITOXIN HEPTAVALENT (A, B, C, D, E, F, G) (EQUINE)
- IrelandDysport 500 units Powder for solution for injectionIpsen Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/27fdd26d-f780-477f-8717-ac099b9d0eec GET /v1/drugs/27fdd26d-f780-477f-8717-ac099b9d0eec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "nie mniej niż 500 j.m. antytoksyny botulinowej typu A, nie mniej niż 500 j.m. antytoksyny botulinowej typu B i nie mniej niż 100 j.m. antytoksyny botulinowej typu E/ml",
"packaging": "05909990053018 ¦ Lz ¦ 946\n1 amp. 10 ml\n05909990763221 ¦ Lz ¦ 56212\n5 amp. 10 ml",
"substance": "Antitoxinum botulinicum monovalens A 5000 j. + Antitoxinum botulinicum monovalens B 5000 j. + Antitoxinum botulinicum monovalens E 1000 j.",
"common_name": "Immunoserum botulinicum",
"pl_product_id": "100204573",
"pozwolenie_nr": "00530",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about botulismus-antitoxin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.